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Background: The prevalence and severity of obesity and associated co-morbidities are rapidly increasing across
the world. Natural products-based drug intervention has been proposed as one of the crucial strategies for
management of obesity ailments. This study was designed to investigate the anti-obesity activities of ethanolic
extract of Terminalia paniculata bark (TPEE) on high fat diet-induced obese rats.
Methods: LC-MS/MS analysis was done for ethanolic extract of T. paniculata bark. Male Sprague–Dawley (SD) rats
were randomly divided into six groups of six each, normal diet fed (NC), high fat diet-fed (HFD), HFD+ orlistat
(standard drug control) administered, and remaining three groups were fed with HFD + TPEE in different doses
(100,150 and 200 mg/kg b. wt). For induction of obesity rats were initially fed with HFD for 9 weeks, then, (TPEE)
was supplemented along with HFD for 42 days. Changes in body weight, body composition, blood glucose, insulin,
tissue and serum lipid profiles, atherogenic index, liver markers, and expression of adipogenesis-related genes such
as leptin, adiponectin, FAS, PPARgamma, AMPK-1alpha and SREBP-1c, were studied in experimental rats. Also,
histopathological examination of adipose tissue was carried out.
Results: Supplementation of TPEE reduced significantly (P < 0.05) body weight, total fat, fat percentage, atherogenic
index, blood glucose, insulin, lipid profiles and liver markers in HFD-fed groups, in a dose-dependent manner. The
expression of adipogenesis-related genes such as Leptin, FAS, PPARgamma, and SREBP-1c were down regulated
while Adiponectin and AMPK-1alpha were up regulated in TPEE + HFD-fed rats. Furthermore, histopathological
examination of adipose tissue revealed the alleviating effect of TPEE which is evident by reduced size of adipocytes.
Conclusions: Together, the biochemical, histological and molecular studies unambiguously demonstrate the
potential anti adipogenic and anti obesity activities of TPEE promoting it as a formidable candidate to develop anti
obesity drug.
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Excessive energy intake over energy expenditure gives
rise to unwarranted growth of adipose tissue leading to
obesity [1,2]. Because of its rising prevalence and its
association with chronic health disorders such as insulin
resistance, hyperlipidemia, hypertension, cardiovascular
diseases, non-alcoholic fatty liver and osteoarthritis,
obesity has turned out to be a major public health* Correspondence: balaji.meriga@gmail.com
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[3,4]. Conventional drug therapies of obesity are often
associated with adverse side effects and rebound weight
gain when drug intake is discontinued. Therefore, re-
search continues to develop safe and effective remedies
to treat obesity. In this context, development of natural
product-based medication is gaining importance because
of its minimum side effects and maximum efficiency.
An array of natural products including plant crude
extracts and their bioactive factors have been reported
to induce weight loss, prevent diet induced obesity and
allied ailments [1]. The possible mechanisms through. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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effects include appetite regulation, interfering in lipid di-
gestion and absorption, fatty acid oxidation, regulating
lipogenesis-lypolysis and adipogenesis [5]. At molecular
level, the major transcription factors such as PPAR γ,
C/EBP α, C/EBP β, SREBP-1c and expression of FAS,
FABPs, leptin, adiponectin, and AMPK-1α have been
implicated in regulating obesity. Previous studies showed
that down regulation of lipogenic and up regulation of
lipolytic proteins contribute to mitigate obesity and dyslip-
idemia in high calorie diet-induced rodent model [5].
PPAR family plays essential role in lipid metabolism and is
majorly expressed in adipose tissue, liver and skeletal
muscle, mediating obesity/anti-obesity signaling events.
AMP-activated protein kinase (AMPK) plays a significant
role in lipogenesis and fatty acid oxidation through in-
activation of acetyl-CoA carboxylase and carnitine
palmitolytransferase-1 [3]. SREBPs are important tran-
scriptional factors, involved in regulation of key enzymes
of lipogenesis including Acetyl Co-A carboxylase (ACC)
and fatty acid synthase (FAS). To make novel therapeutics,
targeting lipid metabolism has been considered as a po-
tential and alternative strategy to combat obesity.
Terminalia paniculata Roth. (Combretaceae) is a trop-
ical tree with a large natural distribution in western and
southern parts of India. Traditionally, its flower juice is
used to treat cholera, inflammation of parotid glands
and menstrual disorders, cough, bronchitis, cardiac de-
bility, hepatitis, diabetes and obesity [6]. The bark is re-
ported to contain 14 % tannins which have a pyrogallol
nucleus along with gallic acid. From the heartwood, phy-
tochemicals such as Ellagic acid, Dimethylellagic acid,
Pentamethyl flavellagic acid, Trimethyl flavellagic acid
and β sitosterol have been isolated [7]. Previously we
have reported the mitigating activity of T. paniculata
against non alcoholic fatty liver [6]. In the present study,
in addition of LC-MS/MS analysis of TPEE, we investi-
gated the attenuating effects of TPEE on body weight,
total fat, fat free mass, fat%, serum lipid profiles and
the levels of leptin, adiponectin, insulin and liver
marker enzymes. We also studied the expression of
certain key regulatory genes associated with lipid me-
tabolism in HFD-induced obese rat model.
Methods
Collection and extraction of plant material
The bark of Terminalia paniculata was collected from
Seshachalam forests, Andhra Pradesh, India. Its identity
was authenticated by a taxonomist, department of Botany,
S.V. University, Tirupati (voucher number 136), and a spe-
cimen has been preserved at the departmental herbarium.
The bark was shade dried, pulverized to a coarse powder
and sequentially extracted with hexane, ethyl acetate,
ethanol and water on their polarity basis. The respectiveextracts were evaporated to dryness in a rotary vacuum
evaporator (Buchi) and later different fractions were
obtained through column chromatography. Based on
phytochemical analysis and preliminary studies, ethano-
lic extract was selected for further studies [8].
LC-ESI-MS/MS analysis ethanolic extract of TPEE
LC-ESI-MS/MS analysis of ethanolic extract of T. panicu-
lata was carried out on 6520 Accurate Q-TOF (Agilent
Santa Clara, CA) mass spectrometer coupled to HPLC
equipped with a UV–vis detector. The column used was
Zobax SB C18 rapid resolution, 4.6 mm × 150 mm,
3.5 μm particle size (Column-SL, Model G1316B). The
conditions were; mobile phase consisted of binary mixture
of solvent (A) formic acid (0.1%) and 10 mM ammonium
phosphate, (B) acetonitrile + 0.1% formic acid; gradient (in
solvent B) with linear gradient programme as follows:
Starting from 95% solvent A and 5% solvent B increasing
to 35% solvent B over 12 min, then increased to 90% over
35 min., back to 5% solvent B over 1 min and finally
isocratic for 10 min. The sample wavelength was set at
240-360 nm. A sample injection volume of 10 μl in
methanol and a constant flow rate of 0.3 ml/min were
used for the analysis of sample. The mass spectra were
acquired with ESI source (Agilent Santa Clara, CA).
Nitrogen was used as the sheath and auxiliary gas and
helium was used as the collision gas. The ESI MS spec-
tra were acquired in positive ion mode and a spray
voltage of 4 kV was employed. The temperature of the
heated transfer capillary was 325°C. The mass spec-
trometer was scanned from m/z 100 to 1200 in full
scan mode, gas flow 10 L/min; Nebulizer 40 psi.
Animals and diets
Male Sprague–Dawley rats (6–8 weeks old), normal pellet
diet and high fat diet were obtained from National Centre
for Laboratory Animal Sciences (NCLAS), National Insti-
tute of Nutrition (NIN), Hyderabad, India. The rats were
housed under 22 ± 2°C temperature, 40–60% humidity
and 12–12 ± 1 h light–dark cycle and allowed food and
water ad libitum. High fat diet composition; Beef thallow
29.5 g, Casein 22.0 g, Starch 23.0 g, Cellulose 17.9 g, L-
Cystiene 4.0 g, Choline chloride 0.3 g, Vitamin mixture
1.8 g, Mineral mixture 1.5 g were used for this study was
obtained from NCLAS, National Institute of Nutrition
(NIN), Hyderabad, India.
Experimental design
Rats weighing 150–170 g were randomly divided in to
six groups of six rats each (n = 6). Normal control group
of rats received a standard pellet containing required
minerals and vitamins, as per AIN-93 guidelines. The
other group of rats received HFD during the course of
the experimental period (15 weeks). Rats were fed with
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of T. paniculata, TPEE (100, 150 and 200 mg/kg b. wt)
was suspended in 0.5% carboxymethyl cellulose and orally
administered to the below mentioned HFD-fed rats for
42 days. All procedures involving laboratory animals
were followed in accordance with the Institute Animal
Ethics Committee regulations approved by the com-
mittee (Resolution No: 36/2012–2013/ (i)/a/CPCSEA/
IAEC/SVU/MB-MRG).
Group 1: Normal control group (NC)
Group 2: High fat diet group (HFD)
Group 3: HFD +Orlistat 5 mg/kg b. wt
Group 4: HFD + TPEE 100 mg/kg b. wt
Group 5: HFD + TPEE 150 mg/kg b. wt
Group 6: HFD + TPEE 200 mg/kg b. wt
Determination of food intake, body weight and body
composition
Throughout the experimental period the weight gain of
rats was monitored weekly and the food intake was
monitored daily. At the end of the experiment, blood
was collected from overnight fasted animals under inhal-
ation of 2% anesthesia by retro-orbital puncture method.
Blood was collected in two different vials, to get plasma
or serum by centrifugation at 2500 rpm for 15 min [9].
For the assessment of body composition, anesthetized
experimental animals were inserted into total body elec-
trical conductivity (TOBEC) using small animal body
composition analysis system (EM-SCAN, Model SA-3000
Multi detector, Springfield, USA). Lean body mass, fat-
free mass, total body fat and fat percentages were calcu-
lated as described previously [10].
Oral glucose tolerance test (OGTT) and Estimation of
fasting blood glucose and insulin
OGTT was performed at the end of the experiment (end
of 15 weeks), after overnight fasting, glucose was admin-
istered orogastrically at a dose of 2.0 g/kg b. wt and
blood samples were collected from supra orbital sinus at
0,30,60,90 and 120 min. Glucose levels were estimated at
all intervals [10].
For estimating fasting blood glucose and insulin levels,
rats were fasted overnight and blood was drawn by retro
orbital puncture method. Blood glucose was estimated
using Kit (Cat No. 1060–500, Stanbio laboratory, USA).
Plasma level of insulin was determined using kits obtained
from Bio-Merieux, RCS, Lyon, France. Insulin resistance
was calculated by homeostasis model assessment.
Serum lipid profiles
For estimation of lipid profiles, blood samples were cen-
trifuged at 2500 rpm/min for 15 min to separate serum
which was then stored at-80°C for further biochemicalanalysis. Total cholesterol, HDL and triacylglyceride levels
were estimated by CHOD-PAP method and GPO-PAP
method [11]. LDL levels were calculated by the method of
Johnson et al. [12]. The atherogenic index (AI) was calcu-
lated by using the method of Muruganandan et al. [13]
and Suanarunsawat et al. [14].
Atherogenic Index AIð Þ ¼ TC‐HDL
HDL
% of Protection ¼ AI of HFD control ‐ AI of treatment group
AI of HFD control
 100
Assay of serum AST, ALT and ALP
Aspartate aminotransaminase (AST), Alanine aminotran-
saminase (ALT), and alkaline phosphatase (ALP) levels
were estimated by assay kit methods according to manu-
facturer’s protocol (Lab Care Diagnostics, India).
Measurement of leptin and adiponectin
Serum leptin and adiponectin levels were measured by
enzyme-linked immunosorbent assay (Crystal Chem,
Downer’s Grove, IL, USA), performed in duplicate and
were expressed in nanograms per milliliter (ng mL-1).
Fecal lipid extraction and estimation
Fecal matter was collected from the experimental rats at
the end of 9th week and 15th week, dried and powdered.
Fecal lipids were extracted with chloroform and metha-
nol (2:1), then dissolved in 1% triton × 100 and esti-
mated by standard kit method [15].
RNA extraction and semi-quantitative PCR
Total RNA was isolated from the adipose tissue of rats
by using tri-reagent (Sigma-Aldrich, USA) according to
manufacturer’s protocol, and reverse transcribed to obtain
cDNA using DNA synthesis kit (A B systems, Foster City,
USA). 20 ng of cDNA was used for semi-quantitative PCR
with specific primers.
The primer sets used for target genes are Leptin (F:
5’ ATGTGGTACGGAAGGTGGAG3’; R: 5’TGGCTA
CCTTCGTCTGTGTG3’), AMPK-1α (F: 5’ GGTCCTG
GTGGTTTCTGTTG3’; R: 5’ATGATGTCAGATGGTG
AATT3’), FAS (F: 5’ GGACATGGTCACAGACGATG
AC3’; R: 5’ GTCGAACTTGGACAGATCCTTCA3’),
PPARγ (F: 5’TCGGTTTGGGCGAATG3’, R: 5’TTTG
GTCAGCGGGAAGG3’), Adiponectin (F: 5’GGTGA
CCAGGAGATGCT3’, R: 5’ TACGCTGAATGCTGA
GTGATA3’), SREBP-1c (F: 5’ GGAGCCATGGATTGC
ACATT3’, R: 5’AGGAAGGTTCCAGAGAGGA3’), RPL-19
(F: 5’CGTCCTCCGCTGTGGTAAA3’, R: 5’AGTACCCT
TCCTCTTCCCTAT3’).
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At the end of the experimental period, animals were
anesthetized with isoflurane and sacrificed. Adipose tis-
sue (fat pads) from each rat was removed, weighed and
stored at-80°C. For histological examination, adipose tis-
sue was fixed in 10% formalin solution and embedded in
paraffin. Standard sections of 5 μm thickness were cut,
stained using hematoxilin and eosin, viewed under an
optical microscope (40X).
Statistical analysis
Results are expressed as mean ± SD (Standard Deviation).
The statistical analysis was carried out by using one-way
analysis (ANOVA). The Duncan test was then applied
using the program SPSS, Version 18, values with p < 0.05
were considered statistically significant.
Results
LC-MS/MS analysis
Previously we reported the preliminary phytochemical
screening of different solvent extracts of T. paniculata
[8]. Here we report the LC-Q-TOF-MS/MS analysis of
the ethanolic extract of T. paniculata and the compounds
present in TPEE. The results of the chromatogram are
shown in Table 1. The following compounds were identi-
fied in TPEE (Ellagic acid, 2’, 4’, 5, 7-Tetramethoxy-8-
Methylflavanone, 3, 3’ di-O-Methyl ellagic acid, Arjunolic
acid, Galloylarjunolic acid, Termilignan and Butalinic
acid). MS/MS Spectra of the mass to charge ratio of ESI
scanned spectra results are shown in Figure 1.
Effect of TPEE on food intake, body weight and body
composition
Food intake, the changes in body weight and body com-
position of experimental rats are shown in Table 2. A
substantial increase in body weights, fat pad weights and
a considerable change in body composition were noticed
in HFD-fed rats when compared to normal control group
rats. However, oral supplementation of TPEE (200 mg/kg
b. wt) significantly (P < 0.05) reduced the body weight,Table 1 LC-ESI-MS/MS analysis of ethanolic extract of T. panic
S.No Compound name Retention time





4 Arjunolic acid 22.746
5 Galloylarjunolic acid 27.373
6 Termilignan 30.836
7 Betulinic acid 33.24lean mass, total fat, fat percentage and fat free mass
of HFD rats when compared to HFD control group
(Table 2).
Oral glucose tolerance test
The results of oral glucose tolerance test of the control
and experimental obese rats are shown in Figure 2. In
normal control rats, maximum elevation in blood glu-
cose level was observed at 60 min after glucose load and
declined to near basal level at 120 min, whereas, in
HFD-induced obese rats, the peak increase in blood glu-
cose level was noticed even after 60 min and remained
high over the next 60 min. Interestingly, supplemen-
tation of TPEE or orlistat to obese rats elicited a sig-
nificant decrease in blood glucose level at 60 min and
beyond when compared with HFD control rats
(Figure 2a).
Estimation of Blood glucose, insulin and insulin resistance
in TPEE treated groups
Estimation of blood glucose, insulin, insulin resistance,
in control and experimental obese rats are depicted in
Table 2. There was a significant (p < 0.05) elevation in
blood glucose, insulin and insulin resistance in HFD
induced obese rats over their normal control rats. Oral
administration of TPEE tended to reverse the changes in
the above parameters in a dose dependant manner, the
maximum activity being observed with 200 mg/kg b. wt
of TPEE.
Effect of TPEE on serum lipid profiles
Feeding on HFD resulted in marked elevation of serum
total cholesterol (TC), tri glycerides (TG), low density
lipoproteins (LDL), very low density lipoproteins (VLDL),
phospholipids and free fatty acids, but reduced high dens-
ity lipoprotein (HDL) levels. However, administration of
TPEE (100, 150, 200 mg/kg b.wt) for 42 days to HFD
groups has significantly (P < 0.05) and dose-dependently
normalized the lipid profiles towards healthy atherogenic
index (Figure 2b,c,d).ulata bark





640.3053 C37H52O9 418, 618
296.1641 C19H20O3 279,496,818
456.3591 C30H48O3 434,444,455,468
Figure 1 LC-ESI-MS/MS analysis of ethanolic extract of T. paniculata. a) Ellagic acid, b) 2’,4’,5,7, Tetramethoxy−8-methylflavanone,
c) 3,3’di-O-Methyl Ellagic acid, d) Arjunolic acid, e) Galloylarjunolic acid, f) Termilignan, g) Betulinic acid.
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The activities of liver marker enzymes such as ALT, AST
and ALP are depicted in Figure 2e. HFD-fed rats exhib-
ited considerably elevated levels of serum ALT, AST and
ALP. However, oral administration of 200 mg/kg b. wt
of TPEE has reduced the levels of ALT, AST and ALP by
52%, 51% and 64% respectively.
Effect of TPEE on leptin and adiponectin
The levels of serum leptin and adiponectin in control
and experimental obese rats are shown in Figure 3a. We
noticed a marked elevation in leptin level and decreased
adiponectin level in HFD-fed obese rats compared to
normal control group. Interestingly oral administration
of 200 mg/kg b. wt of TPEE has significantly (p < 0.05)decreased the leptin and increased the adiponectin levels
in HFD-fed rats.
Effect of TPEE on fat pad deposition and adipose tissue
weights
Vivid differences in fat pad deposition levels were
observed in terms of retroperitoneal, mesenteric and
epididymal tissues, amongst NC, HFD and TPEE
groups. The weights of liver, retroperitoneal, mesen-
teric and epididymal adipose fat pads were markedly
increased in HFD-fed groups. However, administra-
tion of TPEE dose-dependently reduced the weight of
liver and fat pad weights considerably, the maximum
effect being noticed with 200 mg/kg b. wt, as shown
in Table 2.
Table 2 Effect of TPEE on body weights and composition and biochemical parameters of S.D rats
Parameters NC HFD Orlistat TPEE (100) TPEE (150) TPEE (200)
Physiological parameters
† Food intake (g) 20 ± 0.8 24 ± 0.01 19 ± 0.10* 22 ± 0.04 21 ± 0.06* 21 ± 1.14*
‡ Body weight (g) 322.5 ± 14.2 510.8 ± 14.7a* 368 ± 9.1b* 481 ± 8.5NS 456.8 ± 10b* 413.6 ± 12b*
Lean Mass (g) 307.5 ± 11.2 405.5 ± 13.2a* 328 ± 6.8b* 400.7 ± 2.8NS 393.4 ± 10NS 371.2 ± 16b*
Total Fat (g) 15 ± 3.5 105.3 ± 12.8a* 39.6 ± 5.3b* 80.2 ± 8.9 NS 63.3 ± 4.1b* 42.4 ± 5.9b*
Fat Free Mass (g) 139.2 ± 4.5 178.45 ± 13.8a* 147.5 ± 4b* 176.5 ± 9.8NS 173.6 ± 8.9b* 164.7 ± 5.2b*
Fat (%) 4.6 ± 0.9 20.56 ± 1.3a* 10.7 ± 2.3b* 16.6 ± 4.5 NS 13.8 ± 1.2b* 10.2 ± 1.8b*
Anti- hyperglycemic index
Glucose (mg/dl) 70.9 ± 3.4 153.2 ± 8.9a* 96.9 ± 6.2b* 130.9 ± 7.3NS 125 ± 6.5b* 102.4 ± 4.4b*
Insulin 2.2 ± 0.2 7.6 ± 0.8a* 5.2 ± 0.3b* 6.6 ± 0.4NS 6.2 ± 0.3b* 5.9 ± 0.2b*
Insulin resistance 3.3 ± 0.02 5.6 ± 0.01 4.4 ± 0.02 5.2 ± 0.04 4.9 ± 0.05 4.5 ± 0.04
Organ weights
Liver (g) 9.5 ± 0.5 14.7 ± 0.8a* 11.7 ± 0.3b* 13.5 ± 0.5NS 12.3 ± 0.6 b* 11.1 ± 0.3b*
Retro peritoneal (g) 13.9 ± 0.8 4.6 ± 1.1b* 9.5 ± 0.7a* 7.8 ± 0.5NS 7.3 ± 0.6NS 5.2 ± 0.4b*
Mesenteric WAT (g) 1.8 ± 0.4 4.5 ± 0.3a* 2.1 ± 0.2b* 3.7 ± 0.5NS 3.1 ± 0.2b* 2.3 ± 0.2b*
Epididymal WAT (g) 4.1 ± 0.3 8.4 ± 0.5a* 4.4 ± 0.1b* 7.8 ± 0.6NS 7.0 ± 03NS 5.0 ± 0.1b*
Fecal weights and fecal lipids
Initial weight 1.0 ± 0.01 1.3 ± 0.102 1.3 ± 0.42 1.3 ± 0.26 1.3 ± 0.035 1.3 ± 1.20
Final weight 1.3 ± 0.24 1.9 ± 0.031a* 0.9 ± 0.18b* 1.2 ± 0.32NS 1.1 ± 0.02b* 0.98 ± 0.9b*
Fecal lipids (mg/g)
Initial level 7 ± 2.25 12 ± 1.23 12.5 ± 1.2 11.2 ± 1.6 13.2 ± 0.41 13.0 ± 1.02
Final level 9.8 ± 0.19 12.3 ± 1.2a* 16.1 ± 0.2b* 12.8 ± 2.5NS 14.2 ± 0.98b* 15.4 ± 1.08b*
The data are given as mean ± S.D (n = 6). Values are statistically significant at *p < 0.05 aSignificantly different from control, bSignificantly different from HFD
control, NC: Normal control group, HFD: High-fat diet group, TPEE: T. paniculata ethanolic extracts.
The data is analyzed by parametric method-ANOVA.
†: Weighed daily; ‡: Weighed weekly.
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Fecal matter was collected from the rectum and wet
weight of the feces was mesured. Decreased fecal matter
weights were noticed in TPEE adminsitered HFD rats
groups when compared to HFD control group. Further.
Increased excretion of fecal tirglycerides was observed
in orlistat and TPEE treated HFD groups, indicating
that TPEE might reduce lipid digestion and absorption
(Table 2).Effect of TPPE on expression of obesity marker genes
Semi-quantitative PCR analysis of the adipose tissue of
HFD-fed rats showed apparently up regulated expression
of leptin, FAS, PPARγ, SREBP-1c (Figure 3b) and down
regulated expression of adiponectin and AMPK-1α
(Figure 3c). On the other hand, treatment with TPEE
(100,150 and 200 mg/kg b. wt) had dose–dependently
regulated the expression of these genes in HFD-fed
obese groups as depicted in Figures 3b and c. More
particularly TPEE at a dose of 200 mg/kg b. wt could
substantially reverse the expression of respective genes.Effect of TPEE on histopathology
High fat diet consumption resulted in marked enlarge-
ment of adipocytes in HFD control groups. More fat
accumulation and consequently marked expansion of
adipocytes’ size is shown in Figure 4. Enlarged adipo-
cytes and more fat deposits could be noticed in HFD-fed
groups when compared to normal control group. Inter-
estingly supplementation of TPEE (200 mg/kg b. wt) has
considerably reduced the size of adipocytes, on par with
orlistat.Discussion
The prevalence of obesity in recent decades can be at-
tributed largely to changed food habits and increased
sedentary life style. In view of the very limited availabil-
ity of FDA- approved anti-obesity drugs, and considering
their side effects, the quest continues to find novel and
effective natural product based drugs to combat obesity.
Among different targets to treat obesity the ones that
can interfere in the process of lipid mobilization (TG
levels) and lipid deposition are said to be fundamental
Figure 2 Effect of TPEE on biochemical parameters of experimental rats. (a) OGTT (b) Serum lipid profiles (c) Atherogenic index (d) Protection
from atherogenicity (e) Liver marker enzymes (ALT, AST and ALP) in experimental rats. The data are given as mean ± S.D (n = 6). Values are statistically
significant at *p < 0.05 aSignificantly different from normal control, bSignificantly different from HFD control, NC: Normal control group, HFD: High-fat
diet group, TPEE: T. paniculata ethanolic extracts.
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ered to be a good model as they have been reported to
bear close resemblance to human obesity [1]. Rodents fed
on HFD developed visceral adiposity, hyperglycemia,
dyslipidemia, insulin resistance and hepatic steatosis,
which are distinctly linked with human obesity [17]. In the
present study we report LC-MS analysis of ethanolic ex-
tract of Terminalia paniculata (TPEE) and its anti-obesity
activities. In our results we showed that dietary fat and
lipids have profound effect on the development of obesity
in SD rats and this is in concurrence with other studies on
high calorie diet induced higher body fat deposition andincreased body weight [18,19]. Interestingly oral adminis-
tration of TPEE has decreased food intake and signifi-
cantly suppressed higher weight gain, fat percentage, total
fat and fat free mass in HFD-fed rats in a dose-dependent
manner. This could be possibly owing to TPEE’s role to
alter energy expenditure by increasing the expression of
lipolytic proteins [20] or inhibition of lipogenesis by re-
duced expression of FAS and related enzymes [21]. Similar
reports of reduced body weight were previously reported
with extracts of a few plant species including leaves of
Murraya koenigii, resin of Commiphora mukul, piper
against HFD-fed obese rats [22,1,23,24].
Figure 3 Effect of TPEE on leptin, adiponectin levels and mRNA expression of obesity associated genes. (a) Serum leptin and adiponcetin
levels (b) mRNA expression of Leptin, FAS, PPARγ and SREBP-1c in adipose tissue (c) Adiponectin and AMPK-1α expression in adipose tissue of
experimental rats.
Figure 4 Histopathology examination of adipose tissue in experimental rats (40X magnifications). (a) Normal control (b) HFD control
(c) Orlistat 5 mg/kg/ b. wt (d) TPEE 100 mg /kg b. wt (e) TPEE 150 mg/kg b. wt (f) TPEE 200 mg/kg b. wt. N: Nucleus, FD: Fat deposition, AC:
Adipose cell.
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cholesterol, glycerides or LDL concentrations are a risk
factor for coronary vascular diseases, insulin resistance
and non-alcoholic fatty liver [25-27]. Increased free fatty
acid or saturated fatty acid incursion from HFD not only
produces adipogenesis but also leads to metabolic dis-
eases and chronic activation of inflammation [28]. Such
clinical complications of atherosclerosis and obesity
could be reduced when serum lipid concentrations are
lowered by hypocholesterolemic and anti-obesity agents
[29]. In the present study, TPEE administration signifi-
cantly improved lipid profiles in HFD-fed rats as evi-
denced by lowered total cholesterol, triglycerides, free
fatty acids, LDL concentrations and elevated HDL con-
centration in serum, towards a healthy atherogenic
index. In addition, analysis of fecal matter disclosed ele-
vated fecal lipids in HFD + TPEE treated groups than
HFD alone fed group. Increased fecal lipids and de-
creased serum triacylglycerol levels suggest that TPEE
might have anti-lipase activity and also have a role in ab-
sorption and transportation of lipids.
Many reports have shown that long term exposure to
HFD in experimental animals lead to hyperlipidemia,
hyperglycemia and a symptom of insulin resistance [16].
In the present study HFD-induced obese rats developed
a hyperglycemic state associated with insulin resistance
and/or glucose intolerance. However, supplementation
of 200 mg/kg b.wt TPEE showed decreased blood glu-
cose and improved insulin sensitivity in obese rats, as
explained by OGTT, possibly by regulating the cell en-
ergy metabolism or reducing free fatty acids [30]. The
OGTT is advantageous as it is performed under physio-
logical conditions and as it simulates a post absorptive
state in which the production and release of insulin and
its responsiveness are necessary [24].
Liver function tests are important indicators to reveal
the functional status of liver since it is the vital organ in-
volved in detoxification of compounds and in general
metabolism. During diet induced obesity, the liver of
obese rats displayed characteristic features of hepatic
steatosis such as fat accumulation and swelling of rough
endoplasmic reticulum and mitochondria in hepatocytes
[31]. Increased levels of serum ALT, AST and ALP in
HFD group, as shown in the present study indicate alter-
ations in liver metabolic function. TPEE administration
has effectively lowered the HFD-induced elevated levels
of these hepatic enzymes and lipid profiles demonstrat-
ing its protective activity. Our previous studies also
showed the therapeutic activity of TPEE against HFD in-
duced fatty liver [6].
Fat cell formation or adipogenesis is a differentiation
process by which undifferentiated preadipocytes are con-
verted in to fully differentiated adipocytes which store
energy as fat and make the subjects obese [13]. Adiposetissue is a dynamic organ the mass of which changes
during lifetime in response to metabolic requirements of
the animal, and thus, plays an important role in energy
balance. Obesity associated genes such as leptin, FAS,
adiponectin, transcriptional factors (PPARs-α, γ, δ,
SREBPs, C/EBPs) regulate adipogenesis and lipid me-
tabolism at various stages of adipocyte differentiation
[32-34]. It is reported that adiposity is positively corre-
lated to leptin concentration in rodents and humans
[35]. Leptin, a protein mainly secreted by the adipo-
cytes, plays a crucial role in regulating body weight by
controlling the size of the adipose tissue. It regulates
food intake by binding to central nervous system
receptors and by modulating the activity of neurons
present in appetite control centers of the brain [36]. In
our study, down regulation of leptin expression was
found in TPEE + HFD groups possibly leading to de-
creased serum leptin levels which have a direct impact
in satiety behavior. The role of leptin may be consid-
ered for decreased food intake (though not significant)
in TPEE treated groups in our study.
Adiponectin acts as an antagonist of adipogenesis and
plays an effective role in regulating lipid and glucose me-
tabolism in insulin sensitive organs in both animals and
humans [37]. Low concentration of circulating adiponec-
tin level has been demonstrated in diet induced and gen-
etic models of obesity [38]. It has been reported that up
regulation of adiponectin levels is inversely correlated
with body fat mass and insulin resistance [39]. There-
fore, in our study, up regulation of adiponectin levels in
HFD + TPEE administered groups could perhaps ameli-
orate insulin resistance resulting in reduced blood glu-
cose levels, serum lipid concentrations and body weight
loss. PPARγ, an important transcription factor is primar-
ily expressed in adipose tissue and plays an essential role
in the regulation of genes involved in adipocyte differen-
tiation, glucose homeostasis and fat tissue development.
SREBPs are another family of transcription factors but
they are majorly involved in regulation of lipid homeo-
stasis by activating the expression of genes required for
the synthesis and uptake of cholesterol, fatty acid and
triglycerides. Particularly, SREBP-1c, one of the pro adi-
pogenic transcription factors, induces PPARγ expression
and regulates the expression of FAS and AMPK-1α
[40-42]. AMPK plays key role in regulation of lipid and
carbohydrate metabolism through uptake of glucose.
Previous studies have suggested a role for AMPK in the
physiological regulation of fatty acid and glucose metab-
olism, and in the regulation of appetite [34]. In our
study, it was found that adipogenic genes such as leptin,
SERBP-1c, PPARγ and FAS were up regulated while
adiponectin and AMPK-1α were down regulated in
HFD-fed groups. However, we have clearly shown that ad-
ministration of TPEE to HFD-fed groups has considerably
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Figures 3. These results suggest that TPEE could de-
crease body weight and fat mass by down regulation of
SREBP-1c and PPARγ expression, which in turn leads
to inhibited expression of lipogenic enzymes including
FAS. Further, to confirm the anti adipogenic activity of
TPEE, we conducted histopathological examination of
adipose tissue. Our results proved the anti-obesity activity
of TPEE as evident from the reduced size of adipocytes in
TPEE treated groups. Polyphenolic compounds, triterphe-
noids such as ellagic acid, arjunolic acid and their deriva-
tives present in TPEE might be the major bioactive factors
behind its anti-obesity potential. Previous studies demon-
strated the anti-diabetic and anti hyperlipidemic activity of
elllagic acid, betulinic acid and arjunolic acid from differ-
ent plant sources [43,44].
Conclusion
In conclusion, based on physiological, biochemical,
histological and molecular analyses we demonstrate that
ethanolic extract of T. paniculata has potent anti-obesity
activities. The anti-obesity effect of TPEE is likely due to
reduced expression of lipogenic genes such as FAS,
SREBP-1c, PPARγ and leptin and up regulation of adipo-
nectin and AMPK-1α. Finally we suggest that TPEE can
be used as a potential therapeutic alternative for the treat-
ment of obesity.
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